Changes to the Injeq Plc. Board

The Annual General Meeting held on May 31 2022 made the regular decisions as defined in the by-laws.

The new Board of Directors was elected in the Annual General Meeting and the five members are:

Jari Hyttinen
Tommi Majaus
Tomi Numminen
Tommi Rasila
Pekka Tammela

The new Board had the first meeting On June 8, 2022. Tomi Numminen was elected as the chairman of the Board of Directors and Tommi Rasila was elected as the vice-chair.

More information about the Board members is available on the Finnish – site: https://injeq.com/fi/sijoittajille/hallitus/

Injeq participating SIOP 2022 in Barcelona 28th September -1st October

Injeq is very excited to attend the SIOP Congress to present our amazing IQ-Tip system to doctors, patients and their […]
Read more »

Late mortality among survivors of childhood acute lymphoblastic leukemia diagnosed during 1971–2008 in Denmark, Finland, and Sweden: A population-based cohort study

An interesting article from Sørensen et al. about long term survival from childhood ALL (acute lymphoblastic leukemia). According to this […]
Read more »

German reseller Florian Holderer was dazzled by the smart needle

Ecumed’s CEO Florian Holderer emphasizes the importance of user experience and trust in the marketing of the IQ-Tip®​ smart needle. Florian Holderer […]
Read more »

Changes to the Injeq Plc. Board

The Annual General Meeting held on May 31 2022 made the regular decisions as defined in the by-laws. The new […]
Read more »

Incidence of traumatic lumbar punctures in neonates and infants

The part two of the trilogy has now been published. This article of the three part series examines the incidence […]
Read more »

Injeq whitepaper on lumbar puncture

Our whitepaper takes a closer look at the lumbar puncture, the IQ-Tip® system’s first indication, and presents the results that […]
Read more »